Skip to main content
Annals of Oncology logoLink to Annals of Oncology
. 2019 Dec 28;30(12):2018. doi: 10.1093/annonc/mdz455

When is off-label off-road?

E G E de Vries, N I Cherny, E E Voest
PMCID: PMC6938596  PMID: 31893487

Ann Oncol 2019; 00: 1–3 (doi: 10.1093/annonc/mdz445)

The below corrections were inadvertently missed before final publication:

On page 1, in the sentence ‘This trend coincides with increasing concerns about the off-label use of these agent, the costs of these drugs to patients and to the health care system and our ability to learn from off-label use.’- the word ‘agent’ should have been ‘agents’.

On page 2, in the sentence ‘Several countries are now using similar protocols [e.g. TAPUR (NCT02693535) and CAPTUR (NCT03297606) Pro Target] which specifically allow data sharing.’- the words ‘Pro Target’ should have been deleted.

These corrections have now been made. The Publisher apologizes for the error.


Articles from Annals of Oncology are provided here courtesy of Oxford University Press

RESOURCES